Form 4: Bausch Health Director Amy Wechsler Reports Acquisition and Disposal of Shares

Director Amy Wechsler reports acquisition of shares through restricted share units (RSUs) and disposal of shares.

Summary

• Amy Wechsler, a director of Bausch Health Companies Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 16, 2025, Wechsler acquired 54,347 common shares through the grant of restricted share units (RSUs).
• These RSUs, valued at $250,000, were granted to non-employee directors following their election at the Annual Meeting of Shareholders.
• The RSUs vest immediately prior to the next Annual Meeting and are settled in common shares.
• Wechsler also disposed of 54,347 shares.
• Following these transactions, Wechsler beneficially owns 263,355 common shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing is a routine disclosure of director share transactions.

Positives

• The acquisition of shares through RSUs aligns the director's interests with those of the shareholders.

Industry Context

Director share ownership is a common practice to align management and shareholder interests. RSU grants are a typical form of compensation for non-employee directors.

Comparison to Industry Standards

• RSU grants to non-employee directors are a standard practice in publicly traded companies.
• The value of $250,000 is within a typical range for director compensation at companies of Bausch Health's size and industry.
• Companies like AbbVie, Johnson & Johnson, and Novartis also utilize RSU grants as part of their director compensation packages.

Key Dates

Keywords

Bausch Health, Director, Amy Wechsler, Form 4, Beneficial Ownership, RSUs, Shares, Acquisition, Disposal